A voluntary recall notification was issued by Royal Philips (NYSE: PHG, AEX: PHIA) on June 14, 2021 for specific Philips Continuous Positive Airway Pressure (CPAP), Bi-Level Positive Airway Pressure (Bi-Level PAP), and mechanical ventilator devices. This includes devices in the first-generation DreamStation product family. This recall was the result of “identified potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam component of these devices.”
Those who have suffered adverse medical effects or have experienced injuries or cancer due to the device will be looking for legal assistance with their case. Broughton Partners helps connect victims injured by Philips CPAP machines to attorneys that can help them navigate the legal process if they qualify to file a claim.